Evidence map›Paper›PMID 32918817›Full record

ArticleEuropean journal of public health2020

Transitions in product use during the implementation of the European Tobacco Products Directive: cohort study findings from the EUREST-PLUS ITC Europe Surveys.

Constantine I Vardavas, Christina N Kyriakos, Pete Driezen, Charis Girvalaki, Katerina Nikitara, Filippos T Filippidis, Esteve Fernández, Ute Mons, Krzysztof Przewoźniak, Antigona C Trofor and 6 more

Open access · bronzeAbstract read
In one paragraph

Article in European journal of public health, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.6field-weighted citation impact, top 32% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 5 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 16 institutions in 11 countries.

Constantine I VardavasLaboratory of Toxicology, School of Medicine, University of Crete, Heraklion, Greece.
Christina N KyriakosLaboratory of Toxicology, School of Medicine, University of Crete, Heraklion, Greece.
Pete DriezenDepartment of Psychology and School of Public Health and Health Systems, University of Waterloo, Waterloo, Canada.
Charis GirvalakiLaboratory of Toxicology, School of Medicine, University of Crete, Heraklion, Greece.
Katerina NikitaraEuropean Network for Smoking and Tobacco Prevention, Brussels, Belgium.
Filippos T FilippidisEuropean Respiratory Society, Lausanne, Switzerland.
Esteve FernándezTobacco Control Unit, Catalan Institute of Oncology (ICO), L'Hospitalet de Llobregat (Barcelona), Catalonia, Spain.
Ute MonsGerman Cancer Research Center (DKFZ), Cancer Prevention Unit and WHO Collaborating Centre for Tobacco Control, Heidelberg, Germany.
Krzysztof PrzewoźniakHealth Promotion Foundation, Warsaw, Poland.
Antigona C TroforUniversity of Medicine and Pharmacy 'Grigore T. Popa' Iasi, Iasi, Romania.
Tibor DemjénSmoking or Health Hungarian Foundation, Budapest, Hungary.
Paraskevi A KatsaounouEuropean Respiratory Society, Lausanne, Switzerland.
Witold ZatońskiHealth Promotion Foundation, Warsaw, Poland.
Marc WillemsenDepartment of Health Promotion, CAPHRI Care and Public Health Research Institute, Maastricht University, Maastricht, Netherlands.
Geoffrey T FongDepartment of Psychology and School of Public Health and Health Systems, University of Waterloo, Waterloo, Canada.
EUREST-PLUS Consortium
European Network for Smoking and Tobacco Prevention · BEUniversity of Crete · GRFoundation for Polish Science · PLNational and Kapodistrian University of Athens · GRUniversity of Waterloo · CAEuropean Respiratory Society · CHGerman Cancer Research Center · DEGrigore T. Popa University of Medicine and Pharmacy · ROHungarian Institute of Occupational Health · HUMaastricht University · NLBellvitge University Hospital · ESCollegium Civitas · PLImperial College London · GBInstitut d'Investigació Biomédica de Bellvitge · ESOntario Institute for Cancer Research · CAThe Maria Sklodowska-Curie National Research Institute of Oncology · PL

Funding

CIHR FDN-148477
6 · The paper itself

Abstract

backgroundThe emergence of new types of tobacco and tobacco-related products on the European Union (EU) market has precipitated the possibility for both poly-tobacco use and transitions between products. In the EU, the regulatory environment has shifted with the implementation of the European Tobacco Products Directive (TPD) in May 2016, which may influence consumer transitions between products.

methodsThe aim of this paper was to examine trends and transitions in tobacco products from 2016 to 2018 -before and after implementation of the TPD in the EU. Data come from Wave 1 (pre-TPD) and Wave 2 (post-TPD) of the EUREST-PLUS ITC Six European Country Survey, a cohort study of adults who at the time of recruitment were smokers from six EU countries- Germany, Greece, Hungary, Poland, Romania, and Spain. D (N = 3195). Bivariate and logistic regression analyses of weighted data was conducted using SAS-callable SUDAAN.

resultsOverall, among those who smoked factory-made cigarettes (FM) only at Wave 1, 4.3% switched to roll-your-own tobacco (RYO) only. Among RYO only users at Wave 1, 17.0% switched to FM only, however compared to all other countries, respondents from Hungary had the highest percentage of FM only users at Wave 1 switch to RYO only at Wave 2 (18.0%).

conclusionsThe most prominent transition overall was from smoking RYO exclusively at Wave 1 to smoking FM tobacco exclusively at Wave 2, however this varied across countries. As the tobacco control regulatory environment of the EU develops, it is important to continue to monitor transitions between types of products, as well as trends in cessation.

Indexed as

Tobacco ProductsAdultCohort StudiesEuropeGermanyGovernment RegulationGreeceHumansHungaryPolandRomaniaSpainSurveys and Questionnaires

Identifiers

PMID32918817
PMCPMC7526783
OpenAlexW3086028183

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.